Literature DB >> 1755884

The effect of intra-articular instillation of bupivacaine on postarthroscopic morbidity: a placebo-controlled, double-blind trial.

T S Sørensen1, A I Sørensen, K Strange.   

Abstract

Forty patients undergoing diagnostic arthroscopy of the knee were included in a randomized double-blind study to investigate the effect of bupivacaine on postarthroscopic morbidity. The arthroscopies were performed under local anesthesia using 1% lidocaine with adrenaline. At the conclusion of the arthroscopic examination, 10 ml 0.5% bupivacaine with adrenaline or 10 ml placebo was instilled and left in the joint cavity. The two groups of patients were compared with regard to postarthroscopic duration of the anesthesia, degree of postarthroscopic pain, number of analgesic tablets taken, need for crutches or other walking aids, and days away from work. There was no difference between the patients receiving bupivacaine and patients receiving placebo for any of the parameters investigated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755884     DOI: 10.1016/0749-8063(91)90005-i

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  2 in total

1.  Intraarticular tramadol plus pericapsular incisional bupivacaine provides better analgesia than intraarticular plus pericapsular incisional bupivacaine after outpatient arthroscopic partial meniscectomy.

Authors:  Tahsin Beyzadeoglu; Cemil Yilmaz; Halil Bekler; Alper Gokce; Murat M Sayin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-11-10       Impact factor: 4.342

2.  Comparison of intra-articular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors.

Authors:  Sascha Colen; Michel P J van den Bekerom; Johan Bellemans; Michiel Mulier
Journal:  BMC Musculoskelet Disord       Date:  2010-11-16       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.